Chunfu Zheng - University of Calgary -

个人简介

Dr. Chunfu Zheng is selected in the 2022 Global Scholars Academic EliteRanking, one of the world's top 100k scientists, and an Adjunct Professor at the University of Calgary , Calgary, Canada. Dr. Zheng's research is internationally recognized for his contributions to the antiviral innate immunity to herpesviruses, such as herpes simplex virus type 1/2 and varicella-zoster virus, and viral immune evasion mechanism. Dr. Zheng has published more than 120 peer-review biomedical research articles in prestigious journals such as Lancet Microbe, Trends in Microbiology, Signal Transduction and Targeted Therapy, Microbiology and Molecular Biology Reviews (Cover story), FEMS Microbiology Reviews, Blood, Cell Host & Microbe, Signal Transduction and Targeted Therapy, Journal of Medical Virology (10 papers), Cytokine & Growth Factor Reviews (2 papers), Reviews in Medical Virology, Proceedings of the National Academy of Sciences USA, mBio, Journal of Biomedical Science, Cellular and Molecular Life Sciences, Journal of Virology (28 papers, including 1 cover story, 2 spotlighted feature papers), Journal of Immunology (2 papers), Protein and Cell (2 papers). He earned his Ph.D. in Medical Sciences from Chongqing Medical University, China, and completed post-doctoral training at the University of Saskatchewan and University of Calgary in Canada. Before joining Fujian Medical University, Dr. Zheng was a Professor at Wuhan Institute of Virology, Chinese Academy of Sciences, and Soochow University, China. Dr. Zheng has earned numerous awards and distinctions, including the Hundred-Talent Program of the Chinese Academy of Sciences, Top25 reviewers for Journal of Virology (2019, 2020, 2021), and Publons Top 1% peer reviewers (2019-2020). Dr. Zheng serves as an editor of mBio, an Editorial board member of Journal of Virology and Military Medical Research, and an Associate Editor of Journal of Medical Virology, Virology Journal, Frontiers in Immunology, Frontiers in Microbiology, and Gene, Protein and Disease.

近期论文

查看导师新发文章（温馨提示：请注意重名现象，建议点开原文通过作者单位确认）

1 Exploration of the common gene and potential molecular mechanisms between Herpes simplex virus 1 infection and Alzheimer's disease. Liang W, Li X, Wang H, Wang S, Meng Q, Feng R, Zhai J, Xue M, Zheng C. 2 Designing a multi-epitopes subunit vaccine against human herpes virus 6A based on molecular dynamics and immune stimulation. Suleman M, Khan SH, Rashid F, Khan A, Hussain Z, Zaman N, Rehman SU, Zhai J, Xue M, Zheng C. 3 Ocular tropism of SARS-CoV-2 infection. Zhang S, Ju J, Yang F, Zheng C, Zhai J. 4 Future trajectory of SARS-CoV-2: Constant spillover back and forth between humans and animals. Cui X, Wang Y, Zhai J, Xue M, Zheng C, Yu L. 5 Analysis of long noncoding RNAs and messenger RNAs expression profiles in the hearts of mice with acute viral myocarditis. Xue Y, Ke J, Zhang J, Chen M, Zeng L, Fan Q, Zheng C, Chen F. 6 Host antiviral factors hijack furin to block SARS-CoV-2, ebola virus, and HIV-1 glycoproteins cleavage. Yu C, Wang G, Liu Q, Zhai J, Xue M, Li Q, Xian Y, Zheng C. 7 SARS-CoV-2: An Updated Review Highlighting Its Evolution and Treatments. Zhang X, Yuan H, Yang Z, Hu X, Mahmmod YS, Zhu X, Zhao C, Zhai J, Zhang XX, Luo S, Wang XH, Xue M, Zheng C, Yuan ZG. 8 The outbreak of the Ebola virus: Concerns for the animal-to-human spillover. Yang Z, Yuan H, Zhang XX, Zhai J, Xue M, Zheng C, Yuan ZG. 9 When ferroptosis meets pathogenic infections. Gao J, Wang Q, Tang YD, Zhai J, Hu W, Zheng C. 10 3D Bioprinting for Regenerating COVID-19-Mediated Irreversibly Damaged Lung Tissue. Akter F, Araf Y, Promon SK, Zhai J, Zheng C. 11 Marburg virus outbreak in 2022: a public health concern. Araf Y, Maliha ST, Zhai J, Zheng C. 12 Immunoinformatics Approach to Design Novel Subunit Vaccine against the Epstein-Barr Virus. Moin AT, Patil RB, Tabassum T, Araf Y, Ullah MA, Snigdha HJ, Alam T, Alvey SA, Rudra B, Mina SA, Akter Y, Zhai J, Zheng C. 13 Decreased frequency of a novel T-lymphocyte subset, CD3+ CD4- CD7+ CD57- T cells, in hepatitis B virus-related end-stage liver disease might contribute to disease progression. Yu X, Zheng Y, Zeng D, Zhou Y, Sun J, Su M, Zhang H, Zheng M, Huang Z, Lin W, Mao R, Zhang J, Zheng C, Su Z. 14 Differential gene expression profiling reveals potential biomarkers and pharmacological compounds against SARS-CoV-2: Insights from machine learning and bioinformatics approaches. Hoque MN, Sarkar MMH, Khan MA, Hossain MA, Hasan MI, Rahman MH, Habib MA, Akter S, Banu TA, Goswami B, Jahan I, Nafisa T, Molla MMA, Soliman ME, Araf Y, Khan MS, Zheng C, Islam T. 15 The RING finger protein family in health and disease. Cai C, Tang YD, Zhai J, Zheng C. 16 When liquid-liquid phase separation meets viral infections. Wei W, Bai L, Yan B, Meng W, Wang H, Zhai J, Si F, Zheng C. 17 Coinfection of COVID-19 and Dengue: A Case Report. Prapty CNBS, Ahmed N, Araf Y, Yang Z, Zhai J, Hosen MJ, Zheng C. 18 When 3D genome technology meets viral infection, including SARS-CoV-2. Liang W, Wang S, Wang H, Li X, Meng Q, Zhao Y, Zheng C. 19 Spillover infection of common animal coronaviruses to humans. Zhai SL, Sun MF, Zhang JF, Zheng C, Liao M. 20 The Deltacron conundrum: Its origin and potential health risks. Farheen S, Araf Y, Tang YD, Zheng C. 21 Immunoassay and mass cytometry revealed immunological profiles induced by inactivated BBIBP COVID-19 vaccine. Cheng ZJ, Huang H, Liu Q, Zhong R, Liang Z, Xue M, Liu M, Li S, Wang H, Zheng P, Zheng C, Sun B. 22 The Roles of Adipose Tissue Macrophages in Human Disease. Liang W, Qi Y, Yi H, Mao C, Meng Q, Wang H, Zheng C. 23 Immunoinformatic Design of a Multivalent Peptide Vaccine Against Mucormycosis: Targeting FTR1 Protein of Major Causative Fungi. Araf Y, Moin AT, Timofeev VI, Faruqui NA, Saiara SA, Ahmed N, Parvez MSA, Rahaman TI, Sarkar B, Ullah MA, Hosen MJ, Zheng C. 24 Puerarin: A Potential Therapeutic for SARS-CoV-2 and Hantavirus Co-Infection. Liang W, Li X, Wang H, Nie K, Meng Q, He J, Zheng C. 25 Unignorable public health risk of avian influenza virus during COVID-19 pandemic. Ye Y, Ye Z, Yang L, Xiang B, Zheng C. 26 UNC93B1 attenuates the cGAS-STING signaling pathway by targeting STING for autophagy-lysosome degradation. Zhu H, Zhang R, Yi L, Tang YD, Zheng C. 27 Natural infections of SARS-CoV-2 increased in animals: How should humans interact with animals? Zhai SL, Li CL, Sun MF, Zhang JF, Zheng C, Liao M. 28 When Poly(A) Binding Proteins Meet Viral Infections, Including SARS-CoV-2. Gao J, Tang YD, Hu W, Zheng C. 29 When cyclin-dependent kinases meet viral infections, including SARS-CoV-2. Yan Y, Tang YD, Zheng C. 30 When RING finger family proteins meet SARS-CoV-2. Cai C, Tang YD, Zheng C. 31 Novel Molecular Therapeutics Targeting Signaling Pathway to Control Hepatitis B Viral Infection. Yan Y, Qiu Y, Davgadorj C, Zheng C. 32 SARS-CoV-2 and dengue virus co-infection: Epidemiology, pathogenesis, diagnosis, treatment, and management. Prapty CNBS, Rahmat R, Araf Y, Shounak SK, Noor-A-Afrin, Rahaman TI, Hosen MJ, Zheng C, Hossain MG. 33 Insights Into the Coinfections of Human Immunodeficiency Virus-Hepatitis B Virus, Human Immunodeficiency Virus-Hepatitis C Virus, and Hepatitis B Virus-Hepatitis C Virus: Prevalence, Risk Factors, Pathogenesis, Diagnosis, and Treatment. Shahriar S, Araf Y, Ahmad R, Kattel P, Sah GS, Rahaman TI, Sadiea RZ, Sultana S, Islam MS, Zheng C, Hossain MG. 34 Revisiting IRF1-mediated antiviral innate immunity. Zhou H, Tang YD, Zheng C. 35 Omicron variant of SARS-CoV-2: Genomics, transmissibility, and responses to current COVID-19 vaccines. Araf Y, Akter F, Tang YD, Fatemi R, Parvez MSA, Zheng C, Hossain MG. 36 The emerging roles of the CDK/cyclin complexes in antiviral innate immunity. Zheng C, Tang YD. 37 Roles of the polybasic furin cleavage site of spike protein in SARS-CoV-2 replication, pathogenesis, and host immune responses and vaccination. Hossain MG, Tang YD, Akter S, Zheng C. 38 Using the CRISPR-Cas System to Solve Porcine Viral Infection-related Issues. Liao F, Tang YD, Tan L, Yao J, Zheng C, Wang A. 39 DExD/H-box helicases: multifunctional regulators in antiviral innate immunity. Su C, Tang YD, Zheng C. 40 The crosstalk between the caspase family and the cGAS‒STING signaling pathway. Xiong Y, Tang YD, Zheng C. 41 The crosstalk between viral RNA- and DNA-sensing mechanisms. Cai C, Tang YD, Xu G, Zheng C. 42 The crosstalk between pattern-recognition receptor signaling and calcium signaling. Kong F, You H, Zheng K, Tang R, Zheng C. 43 The Critical Role of PARPs in Regulating Innate Immune Responses. Zhu H, Tang YD, Zhan G, Su C, Zheng C. 44 Editorial: Sensing DNA in Antiviral Innate Immunity. Lin R, Xing J, Zheng C. 45 The crosstalk between DNA damage response components and DNA-sensing innate immune signaling pathways. Lin F, Tang YD, Zheng C. 46 When human guanylate-binding proteins meet viral infections. Zhang R, Li Z, Tang YD, Su C, Zheng C. 47 When MARCH family proteins meet viral infections. Zheng C, Tang YD. 48 Author Correction: CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Lang F, Li X, Vladimirova O, Hu B, Chen G, Xiao Y, Singh V, Lu D, Li L, Han H, Wickramasinghe JMASP, Smith ST, Zheng C, Li Q, Lieberman PM, Fraser NW, Zhou J. 49 When Rab GTPases meet innate immune signaling pathways. Su C, Zheng C. 50 When PARPs Meet Antiviral Innate Immunity. Zhu H, Zheng C. 51 The emerging roles of the MARCH ligases in antiviral innate immunity. Zheng C. 52 The emerging roles of NOD-like receptors in antiviral innate immune signaling pathways. Zheng C. 53 Zinc finger proteins in the host-virus interplay: multifaceted functions based on their nucleic acid-binding property. Wang G, Zheng C. 54 The emerging roles of ZDHHCs-mediated protein palmitoylation in the antiviral innate immune responses. Yi L, Zheng C. 55 The Race between Host Antiviral Innate Immunity and the Immune Evasion Strategies of Herpes Simplex Virus 1. Zhu H, Zheng C. 56 Protein Dynamics in Cytosolic DNA-Sensing Antiviral Innate Immune Signaling Pathways. Zheng C. 57 A Tug of War: DNA-Sensing Antiviral Innate Immunity and Herpes Simplex Virus Type I Infection. Lin Y, Zheng C. 58 β-Catenin Is Required for the cGAS/STING Signaling Pathway but Antagonized by the Herpes Simplex Virus 1 US3 Protein. You H, Lin Y, Lin F, Yang M, Li J, Zhang R, Huang Z, Shen Q, Tang R, Zheng C. 59 Bortezomib induces HSV-1 lethality in mice with neutrophil deficiency. Yao HW, Wang LC, Tsai HY, Fang YH, Zheng C, Chen SH, Hsu SM. 60 Herpes Simplex Virus 1 Tegument Protein UL46 Inhibits TANK-Binding Kinase 1-Mediated Signaling. You H, Zheng S, Huang Z, Lin Y, Shen Q, Zheng C. 61 Herpes Simplex Virus 1 UL36USP Antagonizes Type I Interferon-Mediated Antiviral Innate Immunity. Yuan H, You J, You H, Zheng C. 62 Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates cGAS/STING-Mediated Antiviral Innate Immunity. Huang J, You H, Su C, Li Y, Chen S, Zheng C. 63 Evasion of Cytosolic DNA-Stimulated Innate Immune Responses by Herpes Simplex Virus 1. Zheng C. 64 Herpes simplex virus type 1 abrogates the antiviral activity of Ch25h via its virion host shutoff protein. You H, Yuan H, Fu W, Su C, Wang W, Cheng T, Zheng C. 65 The herpes simplex virus 1 UL36USP deubiquitinase suppresses DNA repair in host cells via deubiquitination of proliferating cell nuclear antigen. Dong X, Guan J, Zheng C, Zheng X. 66 Antiviral activity of PHA767491 against human herpes simplex virus in vitro and in vivo. Hou J, Zhang Z, Huang Q, Yan J, Zhang X, Yu X, Tan G, Zheng C, Xu F, He S. 67 Herpes simplex virus 1 infection dampens the immediate early antiviral innate immunity signaling from peroxisomes by tegument protein VP16. Zheng C, Su C. 68 Herpes Simplex Virus 1 UL24 Abrogates the DNA Sensing Signal Pathway by Inhibiting NF-κB Activation. Xu H, Su C, Pearson A, Mody CH, Zheng C. 69 Herpes Simplex Virus 1 Abrogates the cGAS/STING-Mediated Cytosolic DNA-Sensing Pathway via Its Virion Host Shutoff Protein, UL41. Su C, Zheng C. 70 CTCF interacts with the lytic HSV-1 genome to promote viral transcription. Lang F, Li X, Vladimirova O, Hu B, Chen G, Xiao Y, Singh V, Lu D, Li L, Han H, Wickramasinghe JM, Smith ST, Zheng C, Li Q, Lieberman PM, Fraser NW, Zhou J. 71 Herpes Simplex Virus 1 Ubiquitin-Specific Protease UL36 Abrogates NF-κB Activation in DNA Sensing Signal Pathway. Ye R, Su C, Xu H, Zheng C. 72 Herpes Simplex Virus 1 UL41 Protein Suppresses the IRE1/XBP1 Signal Pathway of the Unfolded Protein Response via Its RNase Activity. Zhang P, Su C, Jiang Z, Zheng C. 73 Herpes Simplex Virus 1 Tegument Protein UL41 Counteracts IFIT3 Antiviral Innate Immunity. Jiang Z, Su C, Zheng C. 74 RIG-I-Mediated STING Upregulation Restricts Herpes Simplex Virus 1 Infection. Liu Y, Goulet ML, Sze A, Hadj SB, Belgnaoui SM, Lababidi RR, Zheng C, Fritz JH, Olagnier D, Lin R. 75 Herpes Simplex Virus 1 Serine Protease VP24 Blocks the DNA-Sensing Signal Pathway by Abrogating Activation of Interferon Regulatory Factor 3. Zhang D, Su C, Zheng C. 76 Evasion of host antiviral innate immunity by HSV-1, an update. Su C, Zhan G, Zheng C. 77 Herpes simplex virus 1 UL41 protein abrogates the antiviral activity of hZAP by degrading its mRNA. Su C, Zhang J, Zheng C. 78 Herpes Simplex Virus 1 (HSV-1) and HSV-2 Mediate Species-Specific Modulations of Programmed Necrosis through the Viral Ribonucleotide Reductase Large Subunit R1. Yu X, Li Y, Chen Q, Su C, Zhang Z, Yang C, Hu Z, Hou J, Zhou J, Gong L, Jiang X, Zheng C, He S. 79 Zinc finger antiviral protein inhibits coxsackievirus B3 virus replication and protects against viral myocarditis. Li M, Yan K, Wei L, Yang J, Lu C, Xiong F, Zheng C, Xu W. 80 Conservation of the STING-Mediated Cytosolic DNA Sensing Pathway in Zebrafish. Ge R, Zhou Y, Peng R, Wang R, Li M, Zhang Y, Zheng C, Wang C. 81 Contribution of N-linked glycans on HSV-2 gB to cell-cell fusion and viral entry. Luo S, Hu K, He S, Wang P, Zhang M, Huang X, Du T, Zheng C, Liu Y, Hu Q. 82 RIP1/RIP3 binding to HSV-1 ICP6 initiates necroptosis to restrict virus propagation in mice. Huang Z, Wu SQ, Liang Y, Zhou X, Chen W, Li L, Wu J, Zhuang Q, Chen C, Li J, Zhong CQ, Xia W, Zhou R, Zheng C, Han J. 83 Crystal structure of herpes simplex virus 2 gD bound to nectin-1 reveals a conserved mode of receptor recognition. Lu G, Zhang N, Qi J, Li Y, Chen Z, Zheng C, Gao GF, Yan J. 84 Herpes simplex virus 1 counteracts viperin via its virion host shutoff protein UL41. Shen G, Wang K, Wang S, Cai M, Li ML, Zheng C. 85 PILRα and PILRβ have a siglec fold and provide the basis of binding to sialic acid. Lu Q, Lu G, Qi J, Wang H, Xuan Y, Wang Q, Li Y, Zhang Y, Zheng C, Fan Z, Yan J, Gao GF. 86 Herpes simplex virus 1 protein kinase US3 hyperphosphorylates p65/RelA and dampens NF-κB activation. Wang K, Ni L, Wang S, Zheng C. 87 Herpes simplex virus 1 E3 ubiquitin ligase ICP0 protein inhibits tumor necrosis factor alpha-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1. Zhang J, Wang K, Wang S, Zheng C. 88 Herpes simplex virus 1 serine/threonine kinase US3 hyperphosphorylates IRF3 and inhibits beta interferon production. Wang S, Wang K, Lin R, Zheng C. 89 Interspecies heterokaryon assay to characterize the nucleocytoplasmic shuttling of herpesviral proteins. Wang S, Wang K, Zheng C. 90 Herpes simplex virus 1 ubiquitin-specific protease UL36 inhibits beta interferon production by deubiquitinating TRAF3. Wang S, Wang K, Li J, Zheng C. 91 Herpes simplex virus 1-encoded tegument protein VP16 abrogates the production of beta interferon (IFN) by inhibiting NF-κB activation and blocking IFN regulatory factor 3 to recruit its coactivator CBP. Xing J, Ni L, Wang S, Wang K, Lin R, Zheng C. 92 Herpes simplex virus 1 DNA polymerase processivity factor UL42 inhibits TNF-α-induced NF-κB activation by interacting with p65/RelA and p50/NF-κB1. Zhang J, Wang S, Wang K, Zheng C. 93 The herpes simplex virus 1-encoded envelope glycoprotein B activates NF-κB through the Toll-like receptor 2 and MyD88/TRAF6-dependent signaling pathway. Cai M, Li M, Wang K, Wang S, Lu Q, Yan J, Mossman KL, Lin R, Zheng C. 94 The nucleolus and herpesviral usurpation. Ni L, Wang S, Zheng C. 95 The first identified nucleocytoplasmic shuttling herpesviral capsid protein: herpes simplex virus type 1 VP19C. Zhao L, Zheng C. 96 Herpesviral infection and Toll-like receptor 2. Cai MS, Li ML, Zheng CF. 97 A PY-nuclear localization signal is required for nuclear accumulation of HCMV UL79 protein. Wang L, Li M, Cai M, Xing J, Wang S, Zheng C. 98 Identification of a novel NLS of herpes simplex virus type 1 (HSV-1) VP19C and its nuclear localization is required for efficient production of HSV-1. Li Y, Zhao L, Wang S, Xing J, Zheng C. 99 The potential link between PML NBs and ICP0 in regulating lytic and latent infection of HSV-1. Wang S, Long J, Zheng CF. 100 Live cell imaging fails to support viral-protein-mediated intercellular trafficking. Wu F, Long J, Wang S, Xing J, Li M, Zheng C. 101 Characterization of nuclear import and export signals determining the subcellular localization of WD repeat-containing protein 42A (WDR42A). Wu F, Wang S, Xing J, Li M, Zheng C. 102 Herpes simplex virus 1 tegument protein US11 downmodulates the RLR signaling pathway via direct interaction with RIG-I and MDA-5. Xing J, Wang S, Lin R, Mossman KL, Zheng C. 103 Molecular determinants responsible for the subcellular localization of HSV-1 UL4 protein. Pan WW, Long J, Xing JJ, Zheng CF. 104 Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome. Li Y, Wang S, Zhu H, Zheng C. 105 A novel virus-encoded nucleocytoplasmic shuttling protein: the UL3 protein of herpes simplex virus type 1. Zheng C, Lin F, Wang S, Xing J. 106 Varicella-zoster virus immediate-early protein ORF61 abrogates the IRF3-mediated innate immune response through degradation of activated IRF3. Zhu H, Zheng C, Xing J, Wang S, Li S, Lin R, Mossman KL. 107 Identification of nuclear and nucleolar localization signals of pseudorabies virus (PRV) early protein UL54 reveals that its nuclear targeting is required for efficient production of PRV. Li M, Wang S, Cai M, Zheng C. 108 Characterization of molecular determinants for nucleocytoplasmic shuttling of PRV UL54. Li M, Wang S, Cai M, Guo H, Zheng C. 109 Probing of the nuclear import and export signals and subcellular transport mechanism of varicella-zoster virus tegument protein open reading frame 10. Cai M, Wang S, Long J, Zheng C. 110 Screening and identification of host factors interacting with UL14 of herpes simplex virus 1. Wu F, Xing J, Wang S, Li M, Zheng C. 111 Host cell targets of tegument protein VP22 of herpes simplex virus 1. Li M, Wang L, Ren X, Zheng C. 112 Comprehensive characterization of interaction complexes of herpes simplex virus type 1 ICP22, UL3, UL4, and UL20.5. Xing J, Wang S, Lin F, Pan W, Hu CD, Zheng C. 113 Characterization of the nuclear import and export signals, and subcellular transport mechanism of varicella-zoster virus ORF9. Cai M, Wang S, Xing J, Zheng C. 114 Characterization of the subcellular localization of herpes simplex virus type 1 proteins in living cells. Xing J, Wang S, Li Y, Guo H, Zhao L, Pan W, Lin F, Zhu H, Wang L, Li M, Wang L, Zheng C. 115 Granulysin production and anticryptococcal activity is dependent upon a far upstream enhancer that binds STAT5 in human peripheral blood CD4+ T cells. Xing J, Wu F, Wang S, Krensky AM, Mody CH, Zheng C. 116 Molecular anatomy of subcellular localization of HSV-1 tegument protein US11 in living cells. Xing J, Wu F, Pan W, Zheng C. 117 Real-time imaging of trapping and urease-dependent transmigration of Cryptococcus neoformans in mouse brain. Shi M, Li SS, Zheng C, Jones GJ, Kim KS, Zhou H, Kubes P, Mody CH. 118 Cryptococcus neoformans directly stimulates perforin production and rearms NK cells for enhanced anticryptococcal microbicidal activity. Marr KJ, Jones GJ, Zheng C, Huston SM, Timm-McCann M, Islam A, Berenger BM, Ma LL, Wiseman JC, Mody CH. 119 Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses. Liang R, van den Hurk JV, Zheng C, Yu H, Pontarollo RA, Babiuk LA, van Drunen Littel-van den Hurk S. 120 Effect of different nuclear localization sequences on the immune responses induced by a MIDGE vector encoding bovine herpesvirus-1 glycoprotein D. Zheng C, Juhls C, Oswald D, Sack F, Westfehling I, Wittig B, Babiuk LA, van Drunen Littel-van den Hurk S. 121 Characterization of the nuclear localization and nuclear export signals of bovine herpesvirus 1 VP22. Zheng C, Brownlie R, Babiuk LA, van Drunen Littel-van den Hurk S. 122 Bovine herpesvirus 1 VP22 enhances the efficacy of a DNA vaccine in cattle. Zheng C, Babiuk LA, van Drunen Littel-van den Hurk S. 123 Characterization of nuclear localization and export signals of the major tegument protein VP8 of bovine herpesvirus-1. Zheng C, Brownlie R, Babiuk LA, van Drunen Littel-van den Hurk S. 124 Molecular cloning and sequencing of the merozoite surface antigen 2 gene from Plasmodium falciparum strain FCC-1/HN and expression of the gene in mycobacteria. Zheng C, Xie P, Chen Y. 125 Recombinant Mycobacterium bovis BCG producing the circumsporozoite protein of Plasmodium falciparum FCC-1/HN strain induces strong immune responses in BALB/c mice. Zheng C, Xie P, Chen Y.